136 related articles for article (PubMed ID: 24745683)
61. [Anxiety in general somatic practice].
Filatova EG
Ter Arkh; 2007; 79(5):72-8. PubMed ID: 17672080
[No Abstract] [Full Text] [Related]
62. Neuroinflammatory disorders and mastocytosis: A possible association?
Rodrigues F; Edjlali M; Georgin-Lavialle S; Chandesris O; Barete S; Bouktit H; Dubreuil P; Hamidou M; Saadoun D; Gaillard R; Hermine O
J Allergy Clin Immunol Pract; 2019; 7(8):2878-2881.e1. PubMed ID: 31077881
[No Abstract] [Full Text] [Related]
63. Picture of the month. Mastocytosis.
Truhan AP; Tunnessen WW
Am J Dis Child; 1992 Dec; 146(12):1473-4. PubMed ID: 1456262
[No Abstract] [Full Text] [Related]
64. Mast cell activation disease: An underappreciated cause of neurologic and psychiatric symptoms and diseases.
Afrin LB; Pöhlau D; Raithel M; Haenisch B; Dumoulin FL; Homann J; Mauer UM; Harzer S; Molderings GJ
Brain Behav Immun; 2015 Nov; 50():314-321. PubMed ID: 26162709
[TBL] [Abstract][Full Text] [Related]
65. Mast cells' involvement in inflammation pathways linked to depression: evidence in mastocytosis.
Georgin-Lavialle S; Moura DS; Salvador A; Chauvet-Gelinier JC; Launay JM; Damaj G; Côté F; Soucié E; Chandesris MO; Barète S; Grandpeix-Guyodo C; Bachmeyer C; Alyanakian MA; Aouba A; Lortholary O; Dubreuil P; Teyssier JR; Trojak B; Haffen E; Vandel P; Bonin B; ; Hermine O; Gaillard R
Mol Psychiatry; 2016 Nov; 21(11):1511-1516. PubMed ID: 26809839
[TBL] [Abstract][Full Text] [Related]
66. Mastocytosis in adulthood and neuropsychiatric disorders.
Georgin-Lavialle S; Gaillard R; Moura D; Hermine O
Transl Res; 2016 Aug; 174():77-85.e1. PubMed ID: 27063957
[TBL] [Abstract][Full Text] [Related]
67. Low-dose aripiprazole for refractory burning mouth syndrome.
Umezaki Y; Takenoshita M; Toyofuku A
Neuropsychiatr Dis Treat; 2016; 12():1229-31. PubMed ID: 27279742
[TBL] [Abstract][Full Text] [Related]
68. Isolated flushes without permanent, fixed or other skin lesions in patients with systemic mastocytosis: a case series of 9 patients.
Lafont E; Lhermitte L; Damaj G; Soucie E; Barete S; Chandesris MO; Cabaret L; Guichard I; Durieu I; Retornaz F; Sarrot-Reynauld F; Hamidou M; Bruneau J; Aouba A; Dubreuil P; Lortholary O; Asnafi V; Hermine O; Georgin-Lavialle S
Eur J Dermatol; 2015 Apr; 25(2):182-4. PubMed ID: 25547160
[No Abstract] [Full Text] [Related]
69. Determination of plasma heparin level improves identification of systemic mast cell activation disease.
Vysniauskaite M; Hertfelder HJ; Oldenburg J; Dreßen P; Brettner S; Homann J; Molderings GJ
PLoS One; 2015; 10(4):e0124912. PubMed ID: 25909362
[TBL] [Abstract][Full Text] [Related]
70. Effect of ketotifen in obese patients with type 2 diabetes mellitus.
El-Haggar SM; Farrag WF; Kotkata FA
J Diabetes Complications; 2015 Apr; 29(3):427-32. PubMed ID: 25704652
[TBL] [Abstract][Full Text] [Related]
71. Mixed organic brain syndrome as a manifestation of systemic mastocytosis.
Rogers MP; Bloomingdale K; Murawski BJ; Soter NA; Reich P; Austen KF
Psychosom Med; 1986; 48(6):437-47. PubMed ID: 3749421
[TBL] [Abstract][Full Text] [Related]
72. Long-term efficacy and safety of cladribine (2-CdA) in adult patients with mastocytosis.
Barete S; Lortholary O; Damaj G; Hirsch I; Chandesris MO; Elie C; Hamidou M; Durieu I; Suarez F; Grosbois B; Limal N; Gyan E; Larroche C; Guillet G; Kahn JE; Casassus P; Amazzough K; Coignard-Biehler H; Georgin-Lavialle S; Lhermitte L; Fraitag S; Canioni D; Dubreuil P; Hermine O
Blood; 2015 Aug; 126(8):1009-16; quiz 1050. PubMed ID: 26002962
[TBL] [Abstract][Full Text] [Related]
73. A Practical Guide for Treatment of Pain in Patients with Systemic Mast Cell Activation Disease.
Wirz S; Molderings GJ
Pain Physician; 2017 Sep; 20(6):E849-E861. PubMed ID: 28934791
[TBL] [Abstract][Full Text] [Related]
74. Mast cell-mediated immune regulation in health and disease.
Dileepan KN; Raveendran VV; Sharma R; Abraham H; Barua R; Singh V; Sharma R; Sharma M
Front Med (Lausanne); 2023; 10():1213320. PubMed ID: 37663654
[TBL] [Abstract][Full Text] [Related]
75. Potential Role of Intracranial Mast Cells in Neuroinflammation and Neuropathology Associated with Food Allergy.
Germundson DL; Nagamoto-Combs K
Cells; 2022 Feb; 11(4):. PubMed ID: 35203387
[TBL] [Abstract][Full Text] [Related]
76. Assessing quality of life in patients with mastocytosis: development of the disease-specific questionnaire.
Spolak-Bobryk N; Niedoszytko M; Jassem E; Chełmińska M; Lange M; Majkowicz M; Nedoszytko B; Borchet J
Postepy Dermatol Alergol; 2021 Dec; 38(6):1044-1051. PubMed ID: 35126013
[TBL] [Abstract][Full Text] [Related]
77. Mastocytosis patients' cognitive dysfunctions correlate with the presence of spindle-shaped mast cells in bone marrow.
Spolak-Bobryk N; Romantowski J; Kujawska-Danecka H; Niedoszytko M
Clin Transl Allergy; 2022 Jan; 12(1):e12093. PubMed ID: 35035879
[No Abstract] [Full Text] [Related]
78. Precision Medicine in Systemic Mastocytosis.
Nicolosi M; Patriarca A; Andorno A; Mahmoud AM; Gennari A; Boldorini R; Gaidano G; Crisà E
Medicina (Kaunas); 2021 Oct; 57(11):. PubMed ID: 34833353
[TBL] [Abstract][Full Text] [Related]
79. Mast Cell Deficiency Protects Mice from Surgery-Induced Neuroinflammation.
Zhang X; Dong H; Wang F; Zhang J
Mediators Inflamm; 2020; 2020():1921826. PubMed ID: 32801993
[TBL] [Abstract][Full Text] [Related]
80. Multidisciplinary Challenges in Mastocytosis and How to Address with Personalized Medicine Approaches.
Valent P; Akin C; Gleixner KV; Sperr WR; Reiter A; Arock M; Triggiani M
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31216696
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
